A research study of a new medicine NNC0363-1063 in participants with type 1 diabetes
NN1644-8194
Phase 1 other active
Quick answer
A research study of a new medicine NNC0363-1063 in participants with type 1 diabetes for Diabetes type 1 is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Diabetes type 1
- Phase
- Phase 1
- Modality
- other
- Status
- active